Taken together, these findings indicate that pyrimethamine induces lethal mitophagy in ovarian cancer cells by activating the MAPK pathway by increasing the expression of p-ERK, p-JNK, and p-p38. The gene discussed is MAPK8; the disease is ovarian carcinoma.